Abstract
Background: Autologous stem cell therapy sparks interest and hope in regenerating damaged myocardium while avoiding immune-mediated graft rejection. However, the question whether autologous cells from aged patients is functionally competent for treatment needs to be answered, as most of the heart diseases affect old population.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
